Fig. 2From: Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve diseaseComparison of serum ESM-1 concentration in control, MMVD group with or without comorbidity. No significant difference was found between patients without comorbidities and patients with comorbidities. Abbreviations: ESM-1, endothelial cell-specific molecule-1; MMVD, myxomatous mitral valve diseaseBack to article page